Title |
Accelerating stem cell trials for Alzheimer's disease
|
---|---|
Published in |
Lancet Neurology, December 2015
|
DOI | 10.1016/s1474-4422(15)00332-4 |
Pubmed ID | |
Authors |
Joshua G Hunsberger, Mahendra Rao, Joanne Kurtzberg, Jeff W M Bulte, Anthony Atala, Frank M LaFerla, Henry T Greely, Akira Sawa, Sam Gandy, Lon S Schneider, P Murali Doraiswamy |
Abstract |
At present, no effective cure or prophylaxis exists for Alzheimer's disease. Symptomatic treatments are modestly effective and offer only temporary benefit. Advances in induced pluripotent stem cell (iPSC) technology have the potential to enable development of so-called disease-in-a-dish personalised models to study disease mechanisms and reveal new therapeutic approaches, and large panels of iPSCs enable rapid screening of potential drug candidates. Different cell types can also be produced for therapeutic use. In 2015, the US Food and Drug Administration granted investigational new drug approval for the first phase 2A clinical trial of ischaemia-tolerant mesenchymal stem cells to treat Alzheimer's disease in the USA. Similar trials are either underway or being planned in Europe and Asia. Although safety and ethical concerns remain, we call for the acceleration of human stem cell-based translational research into the causes and potential treatments of Alzheimer's disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 42% |
United Kingdom | 3 | 25% |
Ireland | 1 | 8% |
Unknown | 3 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 58% |
Scientists | 2 | 17% |
Science communicators (journalists, bloggers, editors) | 2 | 17% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | <1% |
China | 1 | <1% |
Germany | 1 | <1% |
Unknown | 187 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 33 | 17% |
Student > Ph. D. Student | 31 | 16% |
Student > Bachelor | 22 | 12% |
Researcher | 22 | 12% |
Professor | 12 | 6% |
Other | 29 | 15% |
Unknown | 41 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 29 | 15% |
Agricultural and Biological Sciences | 28 | 15% |
Medicine and Dentistry | 25 | 13% |
Biochemistry, Genetics and Molecular Biology | 21 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
Other | 34 | 18% |
Unknown | 44 | 23% |